HIV

January 22nd 2025

Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, confirming phase 3 testing results.

January 17th 2025

Women who are using heroin and were recently incarcerated had increased stimulant use, which is associated with adverse outcomes in HIV.

January 15th 2025

Although the association between HIV and long COVID was inconclusive, the prevalence of long COVID in patients with HIV was high.

January 14th 2025

Men who have sex with men (MSM) can now participate in National Blood Donor Month under the FDA's updated guidelines, marking a crucial step toward addressing blood shortages and promoting inclusivity.